Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited OUTSTANDING ADRs AND THEIR IMPACT ON EQUITY SHARES The Company’s ADRs are traded in the US on New York Stock Exchange Inc. (NYSE) under the ticker symbol ‘RDY’. Each ADR is represented by one equity share. As on 31 March 2015, there were approximately 65 registered holders and 12,415 beneficial shareholders of ADRs evidencing 28,773,857 ADRs. QUERIES AND REQUESTS RECEIVED FROM SHAREHOLDERS IN FY2015 Table 7 gives details of types of shareholder queries received and replied to during FY2015. Pending queries and requests were either received during the last week of March 2015, or were pending due to non-receipt of information/documents from the shareholders. DATES AND VENUE OF LAST THREE ANNUAL GENERAL MEETINGS Table 8 gives the details of date, time, location and business transacted through special resolution at last three Annual General Meetings. There is no proposal to conduct postal ballot for any matter in ensuing Annual General Meeting. DISCLOSURE ON LEGAL PROCEEDINGS PERTAINING TO SHARES There are five pending cases relating to disputes over title of the shares of the Company, in which the Company has been made a party. These cases, however, are not material in nature. UNCLAIMED DIVIDENDS/ INTEREST Pursuant to Section 205A of the Companies Act, 1956, unclaimed dividends up to and including for the FY2007 have been transferred to the general revenue account of the Central Government/Investor Education and Protection Fund. The dividends and interest on debentures for the following years, which remain unclaimed for seven years will be transferred to Investor Education and Protection Fund established by the Central Government under Section 205C of the Companies Act, 1956. Table 9 gives the transfer dates in this regard. The Bonus Debentures, issued by the Company in 2011, matured on 24 March 2014. They were redeemed for cash at face value of ` 5 each along with third and final year’s interest. Shareholders/Debenture holders who have not claimed these dividends/interest/redemption amount are, therefore, requested to do so before they are statutorily transferred to the Investor Education and Protection Fund. Shareholders/Debenture holders who have not encashed their dividend/ interest warrants nor claimed the redemption amount on matured debentures as specified in Table 9 are requested to immediately approach M/s. Bigshare Services Private Limited, Hyderabad for the issue of duplicate warrant(s)/demand draft(s) in lieu of the original warrants. NON-COMPLIANCE ON MATTERS RELATING TO CAPITAL MARKETS There has been no instance of noncompliance by the Company relating to capital markets for the last three years. FINANCIAL RESULTS ON COMPANY’S WEBSITE The quarterly, half-yearly and annual results of the Company are displayed on its website www.drreddys.com. Presentations to analysts, as and when made, are immediately placed on the website for the benefit of shareholders and the public at large. Apart from the above, the Company also regularly provides relevant information to stock exchanges as per the requirements of Listing Agreements. INFORMATION ON DIRECTOR PROPOSED FOR RE- APPOINTMENT The information is given in the Chapter on Corporate Governance. QUERIES AT ANNUAL GENERAL MEETING Shareholders desiring any information with regard to the accounts are requested to write to the Company at an early date so as to enable the management to keep the information ready. The queries relating to operational and financial performance may be raised at the Annual General Meeting. The Company provides the facility of Investor-Helpdesk at the Annual General Meeting. Shareholders may post their queries relating to shares, dividends, etc., at this Investor-Helpdesk. PROCEDURE FOR CONVENING AN EXTRAORDINARY GENERAL MEETING Pursuant to the provisions of Section 100 of the Companies Act, 2013 and the Companies (Management and Administration) Rules, 2014, an Extraordinary General Meeting of the Company may be called by a requisition made by shareholders, either in writing or through electronic mode, at least clear twenty one days prior to the proposed date of such extraordinary general meeting. Such a requisition, signed by the requisitionists, shall set out the matters of consideration for which the meeting is to be called and shall be sent to the Registered Office of the Company. Members entitled to make requisition for an Extraordinary General Meeting with regard to any matter, shall be those who hold not less than one-tenth of such of the paid up share capital of the Company as on the date of the requisition, carries the right of voting. PROCEDURE FOR NOMINATING A DIRECTOR ON THE BOARD Pursuant to Section 160 of the Companies Act, 2013, any person, or some member intending to propose such person for appointment as a director of the Company, shall deposit a signed notice signifying candidature to the office of a Director, along with a deposit of ` 1,00,000 (Rupees One Lakh) at the registered office of the Company, not less than fourteen days before the shareholders’ meeting. This amount shall be refunded to such person or the member, if the person proposed gets elected as a director or gets more than 25% of votes. 78
Statutory Reports • Additional Shareholders’ Information Annual Report 2014 - 15 All nominations are considered by the Nomination, Governance and Compensation Committee of the Board of Directors of the Company which entirely comprises of Independent Directors. INFORMATION ON MEMORANDUM AND ARTICLES OF ASSOCIATION The Memorandum and Articles of Association of the Company are available at the corporate website of the Company: www.drreddys.com. limit and has also complied with the provisions of the Investor Education and Protection Fund (Uploading of information regarding Unpaid and Unclaimed amounts lying with Companies) Rules, 2012 The certificate is given by the undersigned according to the best of his knowledge and belief and based on the available information and records, knowing fully that on the faith and strength of what is stated above, full reliance will be placed on it by the shareholders of the Company. CERTIFICATE FROM THE COMPANY SECRETARY I, Sandeep Poddar, Company Secretary of Dr. Reddy’s Laboratories Limited, hereby confirm that as on date of this certificate, the Company has: a. Complied with the provisions of the Listing Agreements with the Stock Exchanges, applicable rules and regulations framed by the Securities and Exchange Board of India and the Companies Act, 1956, as applicable, including Companies Act, 2013 effective as on date, and applicable to the Company b. Complied with the provisions prescribed for Directors’ Identification Number under the Companies Act, 2013 and the Companies (Appointment and Qualification of Directors) Rules, 2014, as amended c. Maintained all books of account and statutory registers prescribed under the Companies Act, 2013 d. Filed all forms and returns and furnished all necessary particulars to the Registrar of Companies and/ or authorities as required under the Companies Act, 2013 e. Conducted the Board meetings and Annual General Meeting as per the Companies Act, 2013 and the minutes thereof were properly recorded in the minutes books f. Effected share transfers and despatched the certificates within the time limit prescribed by various authorities g. Not exceeded the borrowing or investment limits h. Paid dividend to the shareholders, transferred the unpaid dividend to the Investor Education and Protection Fund within the time Place Hyderabad Date 12 May 2015 Sandeep Poddar Company Secretary 79
Page 1 and 2:
ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4:
Our Brand We are in the business of
Page 5 and 6:
Corporate Overview Annual Report 20
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30: Statutory Reports • Business Resp
Page 43 and 44: Statutory Reports • Management Di
Page 57 and 58: Statutory Reports • Corporate Gov
Page 73 and 74: Statutory Reports • Additional Sh
Page 79: Statutory Reports • Additional Sh
Page 87 and 88: Statutory Reports • Board’s Rep
Page 111 and 112: Standalone Financial Statements Ann
Page 131 and 132:
Standalone Financial Statements Ann
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Consolidated Financial Statements A
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Notice Annual Report 2014 - 15 NOTI
Page 229 and 230:
E-Voting Annual Report 2014 - 15 IN
Page 231:
Dr. Reddy’s Laboratories Limited
Page 235 and 236:
The future belongs, not to those wh
show all

Good Health Can’t Wait.

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?